Patent AnalyticsExaminers
Rankings

Law firm or agent

GOODWIN PROCTER LLP/BLUEPRINT

20 applicationsfiled 2013 to 2024

Allowance rate
75%
level with the USPTO range 53% to 89%
Rejections before allowance
0.8
−0.8 vs the USPTO
Months to first action
8.4 mo
−10.2 vs the USPTO
Needed an RCE
20%
−7 pts vs the USPTO

Timeline

Applications by filing year: drag across the years to study a period

Allowed in green, abandoned in red, pending in grey. The figures above and the charts that can be recomputed by filing year follow the span you pick.

Compared with the office

Against every applicant before the USPTO

Unlock the comparison with the officeFree with an account. No card needed.

Create a free account

Trend

Allowance by filing year

Unlock the trendIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Domains

Where the applications fall

CPC subclasses

C07D Heterocyclic compounds9 apps
A61K Medical preparations9 apps
C07K Peptides2 apps

Art units

162414 apps
16212 apps
16991 apps
16221 apps
16281 apps
16271 apps

Who they file for

Clients with the most applications

Bars show the share of decided applications that were allowed.

Unlock the clients they file forIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Rejection fingerprint

What gets rejected, by statute

Share of parsed office actions raising each ground; blue is the USPTO.

Unlock the rejection fingerprintIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

What works

Allowance by strategy used

Unlock what works for this filerIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Interviews

Does an interview help?

Unlock the interview figuresFree with an account. No card needed.

Create a free account

Applications

Every application in the record

ApplicationTitleFiledStatusRejectionsRCEsTo 1st action
19620612CDK2 INHIBITORS FOR TREATMENT OF CANCER2026-09-02Pending00n/a
18605248CDK2 INHIBITORS2024-03-14Allowed009.2 mo
18570274SUBSTITUTED PYRIMIDINYL-PYRAZOLES AS CDK2 INHIBITORS2023-12-14Allowed0026.6 mo
15322360Method and apparatus for adaptive signal processing2012-01-10Allowed1012.0 mo
15937295Composition and method for controlled release2015-02-11Abandoned4123.0 mo
15868312Distributed ledger transaction verification2018-03-12Allowed3020.0 mo
15396739Thermal management of battery assemblies2021-04-13Pending2117.0 mo
15479254Machine learning model for anomaly detection2012-05-14Allowed1014.0 mo
15412137Wireless power transfer coil arrangement2015-06-15Abandoned4125.0 mo
15951683Catalyst for selective hydrogenation2018-07-16Allowed3022.0 mo
Unlock all 20 applications, each with its full timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in